Carcinogenesis Advance Access originally published online on September 24, 2007
Carcinogenesis 2008 29(1):161-168; doi:10.1093/carcin/bgm205
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model
Department of Toxicology, Oncology and Molecular Pathology Unit, University of Cagliari, Via Porcell 4, 09124 Cagliari, Italy
* To whom correspondence should be addressed. Tel: +39 070 6758345; Fax: +39 070 666062; Email: columbano{at}unica.it
-lipoic acid (
-LA) is an antioxidant used in a number of conditions related to liver diseases. Herein, we investigated the effect of
-LA on the development of rat pre-neoplastic lesions generated by a model of hepatocarcinogenesis, which has similarities in its histopathological sequence to human hepatocellular carcinoma development with cirrhosis. Initiation of hepatocytes was achieved by treatment with a single dose of diethylnitrosamine and promotion by feeding a choline–methionine-deficient diet (CMD), with or without
-LA. Pre-neoplastic lesions were identified by their positivity to the placental form of glutathione S-transferase (GSTP) or to gamma glutamyl transpeptidase.
-LA given to rats fed a CMD for 6 weeks dramatically increased the number of GSTP-positive foci as compared with rats fed a CMD alone (96/cm2 versus 7/cm2), the mean foci area (0.033 versus 0.008 mm2) and the percentage of GSTP-positive liver tissue (3.01 versus 0.07%). Essentially similar results were obtained after 10 weeks of treatment. Co-treatment with CMD +
-LA also resulted in the enhancement of fat accumulation, lipid peroxidation and hepatocyte death; increased expression of tumor necrosis factor-
, cytochrome 2E1 and cyclooxygenase-2, enhanced activation of c-jun N-terminal kinase and signal transducer activator of transcription 3, and chronic hepatocyte proliferation was also observed. No such effects were observed when
-LA was added to a choline-supplemented diet. In conclusion, administration of
-LA in conditions associated with hepatic damage aggravates liver injury and stimulates the development of pre-neoplastic lesions; the results also suggest caution in its use in the presence of chronic liver injury.
Abbreviations:
-LA,
-lipoic acid; BrdU, bromodeoxyuridine; CMD, choline–methionine deficient diet; CS, choline-supplemented diet; COX, cyclooxygenase; DENA, diethylnitrosamine; GGT, gamma glutamyl transpeptidase; GSTP, glutathione S-transferase; HCC, hepatocellular carcinoma; JNK, c-jun N-terminal kinase; LPO, lipid peroxidation; mRNA, messenger RNA; ROS, reactive oxygen species; STAT3, signal transducer activator of transcription 3; TNF-
, tumor necrosis factor-
Received July 20, 2007; revised September 5, 2007; accepted September 6, 2007.